Nahid M. Yazdani

Supply chain integration strategies in fast evolving industries

Sander de Leeuw, E Sabet, Nahid M. Yazdani, 2017 .

Small molecule selectively suppresses MYC transcription in cancer cells

Nahid M. Yazdani, P. Schultz, A. Chatterjee, 2017, Proceedings of the National Academy of Sciences.

Pharmacological Characterization of KLYP961, a Dual Inhibitor of Inducible and Neuronal Nitric-Oxide Synthases

Nahid M. Yazdani, T. Rao, A. Shiau, 2011, Journal of Pharmacology and Experimental Therapeutics.

Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS

Nahid M. Yazdani, T. Rao, A. Shiau, 2010, Journal of medicinal chemistry.

Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.

Nahid M. Yazdani, J. Walsh, T. Rao, 2009, Journal of medicinal chemistry.

Heteroaromatic-aminomethyl quinolones: potent and selective iNOS inhibitors.

Nahid M. Yazdani, T. Rao, A. Shiau, 2012, Bioorganic & medicinal chemistry letters.

Primate Spinothalamic Tract Neurons Nitric Oxide Mediates the Central Sensitization of

Nahid M. Yazdani, W. Willis, T. Symons, 2015 .

Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS

Nahid M. Yazdani, T. Rao, A. Shiau, 2010, Journal of medicinal chemistry.